Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Febrile syndromes are among the most common causes of global illness accounting for approximately two billion episodes annually. However, most infections are self-limited and only rarely do they progress to critical illness. Our current inability to rapidly identify the small proportion of individuals who will progress to life-threatening infections (LTIs) is a major barrier to effective triage and precision management of serious infections. Our research has identified biomarkers with high diagnostic accuracy for LTIs. We aim to integrate these diagnostic and prognostic markers with Fio Corporations platform (Fionet) to develop two products: a 1 hour near-patient platform suitable for use in intensive care units and emergency departments; and a point-of-care rapid diagnostic test suitable for community use in low resource settings. The rapid identification of individuals with LTI will decrease mortality and prevent the misallocation of health resources due to over-admission and unnecessary treatment of patients with self-limited fevers.
Kevin Kain
Melissa Richard-Greenblatt
Fio
Biology
Medical devices
Elevate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.